Infection and Drug Resistance
Volume 13, 2020 - Issue
Open access
186
Views
2
CrossRef citations to date
0
Altmetric
Original Research
Ribaxamase, an Orally Administered β-Lactamase, Diminishes Changes to Acquired Antimicrobial Resistance of the Gut Resistome in Patients Treated with Ceftriaxone
John F Kokai-Kun1 Synthetic Biologics, Inc., Rockville, MD, USA
, Chenxiong Le1 Synthetic Biologics, Inc., Rockville, MD, USA
, Kenneth Trout1 Synthetic Biologics, Inc., Rockville, MD, USA
, Julia L Cope2 Diversigen, Inc., Houston, TX, USA
https://orcid.org/0000-0003-4600-5600
Nadim J Ajami2 Diversigen, Inc., Houston, TX, USA
https://orcid.org/0000-0002-3808-8576
Andrew J Degar2 Diversigen, Inc., Houston, TX, USA
& Sheila Connelly1 Synthetic Biologics, Inc., Rockville, MD, USACorrespondence[email protected]
https://orcid.org/0000-0003-0951-3593
Pages 2521-2535
|
Published online: 22 Jul 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.